Question explored with the scientific record
is endometrial biopsy needed if my ultrasound results are normal
The short version: a normal ultrasound does not rule out the condition an endometrial biopsy is looking for, so the decision depends on why you are bleeding, not on the image.
A "normal" transvaginal ultrasound means the endometrial thickness is under a certain cutoff — usually 4 or 5 mm in a postmenopausal woman. That cutoff is good at ruling out cancer but not perfect. In a large 2015 cohort of 4,383 postmenopausal women with bleeding, a 5 mm threshold caught about 93.5% of endometrial cancers but missed 6.5% [8]. The false-positive rate was also high: 1 in 4 women with a thick lining had nothing wrong.
The bigger problem is that ultrasound is terrible at detecting hyperplasia and polyps, which matter because atypical hyperplasia carries a 28% 20-year cancer risk and often coexists with cancer [7]. In one 2016 comparison, transvaginal ultrasound had only 63.2% accuracy for hyperplasia and 65.9% for polyps, while hysteroscopy with biopsy was over 90% accurate for both [5]. Even saline-infusion sonohysterography, a fancier ultrasound, missed about 20% of focal lesions [4].
An office endometrial biopsy (Pipelle) has its own limits. In a 2025 study of 44 women who went on to hysterectomy, Pipelle biopsy had a sensitivity of only 67.6% — meaning it missed nearly 1 in 3 cancers that were found in the full uterus [1]. It also missed about 43% of atypical hyperplasias. A normal biopsy does not rule out disease either.
So the question is not whether the ultrasound is normal. It is whether you have symptoms that warrant a direct look at the tissue. The strongest indication for biopsy is postmenopausal bleeding — any spotting or bleeding after a full year without a period — because about 1 in 10 women with that symptom has endometrial cancer [2]. The risk is also elevated with obesity, diabetes, hypertension, age over 50, or use of tamoxifen or unopposed estrogen [3, 6]. Abnormal uterine bleeding in a premenopausal woman is a more complex call, but persistent heavy or irregular bleeding still justifies sampling even with a normal ultrasound.
| Test | Sensitivity for cancer | Specificity for cancer | What it misses |
|---|---|---|---|
| Transvaginal ultrasound (5 mm cutoff) | ~93.5% [8] | ~74% [8] | Small cancers, most hyperplasia, polyps |
| Office endometrial biopsy (Pipelle) | ~67.6% [1] | ~57.1% [1] | Nearly 1 in 3 cancers, many atypical hyperplasias |
| Hysteroscopy with directed biopsy | ~96.5% [9] | ~93.6% [9] | Small fraction of disease |
No single noninvasive test rules out endometrial disease. The ultrasound is a screening tool, not a final answer.
My call: if you are postmenopausal and bleeding, a normal ultrasound is not enough — you still need an endometrial biopsy. If you are premenopausal with abnormal bleeding that persists or is heavy, a normal ultrasound reduces your risk but does not eliminate it, and a biopsy is reasonable if symptoms continue. Confidence: high — the evidence is consistent and direct, though the numbers come from studies with known limits (moderate sample sizes, operator-dependent imaging, retrospective designs).
Sources used 9
-
Concordance and Discordance of Endometrial Biopsy vs Hysterectomy Specimen Findings for the Diagnosis of Endometrial Cancer
Endometrial biopsy shows moderate concordance with hysterectomy findings for diagnosing and grading endometrial cancer, with a sensitivity of about 67.6%, specificity about 57.1%, and overall grading agreement around 52.3%, highlighting biopsy as a useful but imperfect preoperat…
DOI: 10.30683/1927-7229.2025.14.06 -
Hysteroscopy in postmenopause: from diagnosis to the management of intrauterine pathologies
A state-of-the-art narrative review detailing the role of hysteroscopy in the diagnosis and management of intrauterine pathologies in postmenopausal women, outlining indications, techniques, outcomes, and safety considerations.
DOI: 10.1080/13697137.2020.1754387 -
No. 291-Epidemiology and Investigations for Suspected Endometrial Cancer
A clinical guideline reviewing the epidemiology of endometrial cancer and outlining evidence-based diagnostic workups for suspected endometrial cancer, including endometrial sampling, imaging, and preoperative assessment to guide treatment planning.
DOI: 10.1016/j.jogc.2018.07.005 -
Diagnostic value of saline infusion sonohysterography for detecting endometrium focal leson
This cross-sectional study evaluates the diagnostic value of saline infusion sonohysterography (SIS) for detecting endometrial focal lesions in women with abnormal uterine bleeding, finding SIS has good sensitivity and specificity—better than transvaginal ultrasound but not supe…
DOI: 10.11604/pamj.2019.33.211.16563 -
Accuracy of Transvaginal Ultrasonography, Hysteroscopy and Uterine Curettage in Evaluating Endometrial Pathologies
Hysteroscopy with directed biopsy yielded diagnostic accuracy above 90% for endometrial polyps, submucous myomas, and endometrial hyperplasia, outperforming transvaginal ultrasonography and uterine curettage.
DOI: 10.1055/s-0036-1593774 -
Risk factors of endometrial cancer in patients with endometrial hyperplasia: implication for clinical treatments
Endometrial cancer occurs in 31.58% of endometrial hyperplasia patients undergoing hysterectomy, with age over 50, BMI ≥25, diabetes, hypertension, and severe hyperplasia independently increasing cancer risk.
DOI: 10.1186/s12905-021-01452-9 -
Absolute Risk of Endometrial Carcinoma During 20-Year Follow-Up Among Women With Endometrial Hyperplasia
This study provides a comprehensive analysis of the absolute risk of progression to endometrial carcinoma among women diagnosed with endometrial hyperplasia, revealing that cumulative 20-year progression risk is less than 5% for nonatypical hyperplasia but significantly higher a…
DOI: 10.1200/JCO.2009.24.1315 -
Reappraisal of endometrial thickness for the detection of endometrial cancer in postmenopausal bleeding: a retrospective cohort study
This retrospective cohort study evaluates the accuracy of transvaginal ultrasound measurement of endometrial thickness in diagnosing endometrial cancer among postmenopausal women with vaginal bleeding, finding high sensitivity at various cut-off values.
DOI: 10.1111/1471-0528.13342 -
Hysteroscopy and transvaginal ultrasonography in postmenopausal women with uterine bleeding
This study evaluates the accuracy of hysteroscopy and transvaginal ultrasonography in diagnosing endometrial pathology in postmenopausal women with uterine bleeding, finding that hysteroscopy is more accurate than ultrasonography, especially when combined with endometrial thickn…
DOI: 10.1016/s0020-7292(98)00224-0